Related Experiment Videos
Evolving experience with thoracic aortic stent graft repair.
Richard P Cambria1, David C Brewster, Stephen R Lauterbach
1Department of Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA. rcambria@partners.org
Journal of Vascular Surgery
|June 4, 2002
Summary
Thoracic aorta (TA) stent grafting is a safe and effective alternative to open repair for various TA diseases. Commercial devices offer superior ease and accuracy compared to homemade options.
Area of Science:
- Cardiovascular Surgery
- Interventional Radiology
Background:
- Thoracic aorta (TA) diseases encompass a range of conditions including aneurysms, dissections, and intramural hematomas.
- Open surgical repair of TA pathologies can be associated with significant morbidity and mortality, particularly in patients with comorbidities.
Purpose of the Study:
- To evaluate the initial experience with thoracic aorta (TA) stent grafting in 28 patients.
- To compare the outcomes of homemade stent grafts (Dacron over Gianturco Z stents) with a commercial device (Excluder).
Main Methods:
- A retrospective review of 28 patients undergoing TA stent grafting between November 1996 and August 2001.
- Patients presented with diverse TA pathologies, including degenerative aneurysms, chronic dissections, and pseudoaneurysms.
- The study compared 14 patients treated with homemade devices and 14 with a commercial device, noting patient demographics, comorbidities, and procedural details.
Main Results:
- The procedural mortality rate was 3.5% (1/28), with one additional device-related death during follow-up (mean 17 months).
- Access artery complications occurred in 21% of patients, with one fatality. Complete exclusion of TA lesions was achieved in 96% of cases.
- Commercial devices demonstrated superior ease and accuracy of deployment compared to homemade devices. No spinal cord ischemia was noted.
Conclusions:
- Thoracic aorta (TA) stent graft repair is a safe and effective alternative for managing a spectrum of TA diseases.
- Further prospective trials are needed to define the specific role of TA stent grafting for individual pathologies.